Blood Cancer United Research

Doing the most for more people with blood cancer.
We are the Research team of @bloodcancerutd.
We're all about cutting-edge blood cancer research to find a cure

[Blood Cancer United @BloodCancerUtd]

Primary-Refractory acute myeloid leukemia (AML) is a form of leukemia that doesn’t respond to initial treatment, making continued progress in care options especially important. Michael Bern, MD, PhD is working to understand why this happens and how future therapies could offer more effective paths forward. ❤️

It’s one of the many ways we’re committed to AML research 👉 https://t.co/QSebCTUTV1

[Blood Cancer United @BloodCancerUtd]

The @US_FDA has approved a new treatment for high-risk smoldering multiple myeloma, a breakthrough that’s reshaping early-stage care. ❤️

More on what this means for patients 👉 https://t.co/jzWqLW5xZa

[Blood Cancer United @BloodCancerUtd]

The Dare to Dream Summit may be over, but the impact is just beginning. ❤️

Over 250 attendees united together to share ideas, drive progress, and push for more support for young people with blood cancer.

A huge thank you to the incredible teams who brought it all to life - both on stage and behind the scenes.

The work continues, and so does our commitment to this community. 🫶🌟🫂 @bcutd_advocacy

[Blood Cancer United @BloodCancerUtd]

For those living with acute myeloid leukemia (AML), more options mean more hope. ❤️

The @US_FDA has expanded approval of a targeted therapy for AML, offering new treatment possibilities for more patients.

Blood Cancer United supports research to better understand AML and identify new treatment approaches through scientific grants, clinical trials like Beat AML and Pediatric Acute Leukemia (PedAL), and our Therapy Acceleration Program®.

Learn more about our ongoing commitment to AML research 👉 https://t.co/xGLPQKQkQO

[Blood Cancer United @BloodCancerUtd]

Behind every research breakthrough are the people who want more birthdays, milestones, and everyday moments with the ones they love. ❤️

Together with the @HCLFoundation, we’re investing up to $7 million in the HCL2030 program to push research forward and create better options for patients with hairy cell leukemia.

This continued collaboration will open up new therapeutic options for individuals with hairy cell leukemia (HCL). We proudly supported earlier work by Dr. Tiacci leading to a new treatment for people with relapsed HCL.

On World Cancer Research Day, we honor patients at the heart of this mission, and the researchers who are making progress possible 👉 https://t.co/quwXzYIci6

[Blood Cancer United @BloodCancerUtd]

#ICYMI: Blood Cancer United lit up the @Nasdaq billboard in Times Square yesterday! 🎉 Our co-workers pulled up to celebrate this iconic moment—united we’re unstoppable. 🫶

[Blood Cancer United @BloodCancerUtd]

We do the most for people with blood cancer. So people with blood cancer, can do more of whatever they want. 🫶

The Leukemia & Lymphoma Society is now Blood Cancer United. ✨📢🎉

Learn more 👉 https://t.co/cvyEaDrLh7

[Blood Cancer United Research @bcutd_research]

What’s changed? 📣 Our name! We’re now the research team of @bloodcancerutd. What hasn’t? Our drive to fund bold research, fuel discoveries, and make life’s little moments possible—morning pancakes, movie nights, first-day-of-school walks. 🩸🔬

[Blood Cancer United @BloodCancerUtd]

We’ve been gatekeeping long enough! 🔑

For more than 75 years, we’ve been committed to creating a world without blood cancer. While our mission hasn’t changed, today, our name does. 📣

📰 Headline this moment—go!👇

[Blood Cancer United Research @bcutd_research]

Zoom in! 🔎 Can you find the first comment in @LLSusa's post? 🤫 You’ll want to be here tomorrow 👀

[Blood Cancer United @BloodCancerUtd]

Look closer 🔍

[Blood Cancer United @BloodCancerUtd]

Have you received CAR T-cells and wondered about possible effects on your fertility?

Help us gather critical information to determine if CAR T-cells affect fertility:

Who can participate?
✅ Adults over the age of 18
✅ Received CAR T-cell therapy as a result of a blood cancer diagnosis

Questions?
✉️ Email: [email protected]
📞 Call: 914-821-8408

Take the survey today 👉 https://t.co/cGFoeWiLKE #CART

[Blood Cancer United Research @bcutd_research]

@CterminiPhD Excellent choice for a Co-I. Adding an established PI such as Lenny will surely elevate your proposal. Sending you 🍀

[Blood Cancer United Research @bcutd_research]

Basic blood cancer research funding opportunity! 🩸🔬
@LLSusa is now accepting LOIs for the Discovery Grant Program (DGP).
Looking for foundational research projects to shed a new light on any or all of the blood cancers.

Follow the link more and apply:
👉https://t.co/4Y1umRA5cq

[Blood Cancer United Research @bcutd_research]

Are you an early or mid-career blood cancer scientist/clinician?

Our CDP grant program may just be the right fit for you!
Visit our website for guidelines, deadlines and eligibility👉https://t.co/xwqo8OxWFg

Please repost and share! 🩸🔬

[Blood Cancer United Research @bcutd_research]

@EinsteinMed @The_Will_Lab @Einstein_SCI @EinsteinCellBio @MontefioreNYC @EinsteinPhD Congratulations, Dr. Will!
Signed: your friends at LLS 😉🩸

[Blood Cancer United Research @bcutd_research]

Look at him go!
What can't @StefBPhD do? He is a rising 🌟of a leukemia scientist and a CDP Fellow, he runs marathons and raises funds for LLS 🩸
Read more about his project here:
👉 https://t.co/AX3gOPScAG

[Blood Cancer United @BloodCancerUtd]

“This family of diseases is devastating, and I am committed to finding new ways to cure them. As a recipient of a competitive LLS fellowship, I eagerly accepted the opportunity to raise funds for LLS through @teamintraining (TNT).” - Stefan, marathoner, research fellow, and medical trailblazer. Read his story 👉 https://t.co/tuOmIXfoD7

[Blood Cancer United Research @bcutd_research]

We're so excited about our new #LLSTAP partner @Solu_Tx! Our investment in the Series A helps us advance our mission to improve outcomes for all blood cancers—including rare, serious diseases like #CMML. Learn more 👉https://t.co/HTbtiuHEft

[Solu Therapeutics @Solu_Tx]

We’re grateful for the support of @LLSusa through their Therapy Acceleration Program (TAP). This new partnership will help drive our efforts in hematological malignancies, particularly #CMML, as we work toward innovative solutions for patients. Read more: https://t.co/gUri7r6c9Z

[Urvi Shah @UrviShahMD]

Thank you @LLSusa for funding our dietary research in newly diagnosed myeloma @MSKCancerCenter @MSK_DeptOfMed

Enjoyed chatting with @DrGwenNichols @LLSusa for #MyelomaAwarenessMonth and #WomensHistoryMonth #mmsm

Link here: https://t.co/RTFhz8Hh4r

[Blood Cancer United Research @bcutd_research]

@SchoolLonsdale @FeinsteinFound @KevinJ_McNamara @LFilippelli1 Thank you 🙏🩸

[Blood Cancer United @BloodCancerUtd]

Progress in action. ❤️ The @US_FDA has approved a new treatment combination for adults with large B-cell lymphoma, offering hope for those whose cancer has returned or worsened. Get the details 👉 https://t.co/VGWZkXLHaV

[Blood Cancer United Research @bcutd_research]

@DrTonyLetai Congratulations on the exceptional offspring!
Voting early and often 🫡